Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
Lemonade (LMND) Delivers Accelerating Growth in Q3 2026 Earnings

Lemonade (LMND) Delivers Accelerating Growth in Q3 2026 Earnings

Key Takeaways

  • Lemonade reported a third quarter 2026 net loss of $0.56 per share, slightly better than the $0.58 consensus loss, while revenue of $336.1 million topped estimates by roughly $13.6 million.
  • Revenue grew about 73% year over year, extending a streak of accelerating top-line growth driven by rising premium retention and cross-sales to existing customers.
  • In-force premium (IFP), the total annualized value of active policies, reached $1.55 billion, up 34% year over year and marking a 12th consecutive quarter of accelerating growth.
  • The gross loss ratio climbed to 65%, up from 60% in the prior quarter, as higher pet insurance claims costs and catastrophe and large losses in Europe pressured underwriting margins.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was a loss of $20 million, while adjusted free cash flow stayed positive for a sixth straight quarter at $27 million.
  • Management raised full-year revenue guidance and reiterated its target of a positive adjusted EBITDA quarter in Q4 2026.

Why the Report Matters

Lemonade, Inc. (NYSE: LMND) is a digital insurance company that uses artificial intelligence and behavioral economics to offer renters, homeowners, pet, car, and life insurance. Its third quarter 2026 report matters because investors are watching two competing storylines at once: whether the company can keep delivering unusually rapid premium and revenue growth, and whether it can convert that growth into sustainable underwriting profitability. Coming into the print, shares had pulled back sharply from late-summer highs and traded well below their 200-day moving average, reflecting growing caution about rising loss ratios in the pet segment and in Europe. The report therefore carried outsized weight as a test of both the growth narrative and the credibility of management's near-term profitability targets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Breaking Down the Reported Results

For the third quarter ended September 30, 2026, Lemonade reported revenue of $336.1 million, up about 73% year over year and above the roughly $322.7 million consensus estimate. The company posted a GAAP net loss of $0.56 per share, beating the $0.58 consensus loss by $0.02. In-force premium reached $1.55 billion, up 34% year over year, and the company added roughly 212,000 new customers, a 20% increase from the prior-year quarter.

Beneath the top line, results were mixed. Gross profit rose 48% to $118 million, with adjusted gross profit up 49% to $121 million. However, the gross loss ratio deteriorated to 65%, up from 60% in Q2, driven primarily by veterinary cost inflation in pet insurance and elevated catastrophe and large losses in Europe. Annual dollar retention ticked up one point sequentially to 86%, and adjusted EBITDA improved to a loss of $20 million. On guidance, management guided fourth quarter revenue to $342 million to $346 million and raised full-year 2026 revenue guidance to $1.23 billion to $1.24 billion, both above consensus, while keeping the Q4 adjusted EBITDA outlook at $5 million to $9 million.

Market Reaction and Sentiment

Heading into the report, sentiment had already cooled. Lemonade shares slid from a high around $56.58 in late August to a 52-week low near $39.60 in early November before rebounding to about $45.90 the day before earnings. The print delivered a headline beat on both the top and bottom lines, along with a third consecutive quarter of raised revenue guidance, which typically supports a positive initial reaction. At the same time, the deterioration in the gross loss ratio, the flat Q4 adjusted EBITDA guidance, and a flagged shelf registration renewal that could raise dilution concerns gave investors reasons to remain cautious. The central tension following the report is that growth is clearly accelerating, but the path from revenue growth to underwriting profit has not visibly shortened.

Forward Outlook and Factors to Watch

Lemonade's near-term story now hinges on whether management can deliver on its reiterated commitment to a positive adjusted EBITDA quarter in Q4 2026 and positive adjusted EBITDA for the full year 2027. Investors should watch operating expense trends closely, particularly growth spend, which management said will slow significantly beginning in the fourth quarter, and stock-based compensation, which is expected to stop driving year-over-year expense growth by Q2 2027.

On the underwriting side, the pet insurance loss ratio remains the most important swing factor, given that pet makes up roughly 40% of the business and continues to face industry-wide veterinary cost inflation. Europe also requires rate action after absorbing 29 points of catastrophe and large losses in the quarter. Any meaningful improvement or further deterioration in these two areas will likely shape how the market interprets the company's progress toward profitability.

Finally, growth catalysts remain active. Renters insurance is now available in all 50 states, car insurance has expanded into Florida, Missouri, and Pennsylvania, and the autonomous-vehicle product is live in six states, where Tesla owners convert at roughly 2.2 times the broader car rate. Cross-sales surpassed $100 million year to date and are growing about twice as fast as in-force premium, suggesting that existing customers are becoming a larger engine of growth. These levers give Lemonade multiple avenues to sustain momentum, but the durability of underwriting margins will determine whether that momentum translates into a healthier bottom line. From what I see, the balance between growth and margin control will be the key narrative into year-end.

Using AI Tools for Deeper Analysis

In my own research process, I turned to Tickeron’s AI Screener to quickly compare Lemonade’s metrics against peers in the insurance and fintech space. It helped surface relevant technical and fundamental filters that highlighted how the company’s accelerating premium growth stands out, even as loss ratios remain a watch item. This kind of structured scanning makes it easier to stay on top of names like this without manually digging through dozens of reports.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LMND

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


LMND in +11.43% Uptrend, growing for three consecutive days on November 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where LMND advanced for three days, in 217 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 65 cases where LMND's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

LMND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LMND as a result. In 74 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for LMND turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 43 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LMND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for LMND entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.427) is normal, around the industry mean (-2.158). LMND has a moderately low P/E Ratio (-22.791) as compared to the industry average of (9.893). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.303). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. LMND's P/S Ratio (3.769) is very high in comparison to the industry average of (1.594).

The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. LMND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LMND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 50, placing this stock worse than average.

Industry description

Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.

Market Cap

The average market capitalization across the Property/Casualty Insurance Industry is 14.48B. The market cap for tickers in the group ranges from 0 to 143.37B. CB holds the highest valuation in this group at 143.37B. The lowest valued company is FXFLF at 0.

High and low price notable news

The average weekly price growth across all stocks in the Property/Casualty Insurance Industry was -0%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 21%. HGTY experienced the highest price growth at 19%, while MCY experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Property/Casualty Insurance Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was 67% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 60
Price Growth Rating: 41
SMR Rating: 69
Profit Risk Rating: 50
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an insurance holding company, which engages in the provision of home and renters insurance services

Industry PropertyCasualtyInsurance

Industry
N/A
Address
5 Crosby Street
Phone
+1 844 733-8666
Employees
1282
Web
https://www.lemonade.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
ExxonMobil reported GAAP net earnings of $4.2 billion, or $1.00 per diluted share (EPS), down from $7.7 billion, or $1.76 per share, in Q1 2025. Adjusted earnings excluding identified items reached $4.9 billion, or $1.16 per share, surpassing consensus estimates around $1.00 to $1.07.